1. Менопаузальный синдром (клиника, диагностика, профилактика и заместительная гормональная терапия). Под ред. В.И.Кулакова, Е.М.Вихляевой. М., 1996; 64.
2. Прилепская В.Н., Межевитинова Е.А., Тагиева А.В. Внутриматочная контрацепция: Руководство. М.: МедПресс, 2000; 325.
3. Ревазова Ф.С. Клинико-морфологические особенности внутриматочной контраепции: Автореф. ... дис. канд. мед. наук. 2003; 26.
4. Тагиева А.В. Эффективность и приемлемость левоноргестрел-содержащего внутриматочного средства "Мирена" у женщин репродуктивного возраста: Автореф. дис...  канд. мед. наук. 2001; 26.
5. Andersson K, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Brit J Obstet Gynecol 1990; 97: 690–4.
6. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copperreleasing (Nova T) IUDs during five years of use: a randomisod comparative trial. Contraception 1994; 49 (1): 56–72.
7. Antoniou G, Kalogirou D, Karakitosos P et al. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for ckunacteruc complaints versus estradiol- releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses. Maturitas 1997; 26 (2): 103–11.
8. Barbosa I, Bakos O, Olsson S et al. Ovarian function during use of levonorgestrel-releasing IUD. Contraception 1990; 42: 51–66.
9. Barrington J, Bowen-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Brit J Obstet Gynaecol 1997; 104 (5): 614–6.
10. Barrington JW, Leary AO, Bowen-Sinpkins P. Management of refractory pre-menstrual syndrome using subcutaneous oestradiol implants and levonorgestrel intrauterine systems. J Obstet Gynecol 1997; 17 (4): 416–7.
11. Coleman M, Cowan L, Farquhar C. The levonorgestrel-releasing intrauterine device: a wider role than contraception. Aust. NZ Obstet Gynaecol 1997; 37 (2): 195–202.
12. Critchley H, Wang H, Kelly R et al. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using using a levonorgestrel-releasing intrauterine system. Hum Reprod 1998; 13 (5): 1210–710.
13. Crosignani P, Vercellini P, Mosconi P at al. Levonorgestrel-releasing intrauterine device versus Hysteroscopic endometrial resection in the treatment of dycfunctional uterine bleeding. Obstet Gynecol 1997; 90: 257–63.
14. Greendale G, Lee N, Arriola E. The menopause. Lancet 1999; 353 (9152): 571–80.
15. Gu Z, Zhu P, Luo H at al. Morphometric study on the endometrial activity of woment before and after one year with LNG-IUD in situ. Contraception 1995; 52: 57–61.
16. Fedele L et al. Use of the levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis Fert. Steril 2001; 75: 485–8.
17. Hurk P, O'Brien S. Non-contraceptive use of the levonorgestrel-releasing intrauterine system. Obstet Gynaecol 1999; 1 (1): 13–9.
18. Irvine G, Campbell-Brawn M, Lumsden M at al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of ikiopathic menorrhagia. Brit J Obstet Gynaecol 1998; 105 (6): 592–8.
19. Jarvela I, Tekay A, Jouppila P. The effect of a levonorgestrel-releasing intrauterine system on uterine artery bloodflow, hormone contrations and ovarian cyst formation in fertile women. Hum Reprod 1998; 13 (12): 3379–83.
20. Johansson E. Future aspects of the levonorgestrel-releasing intrauterine system. Gynecoly Forum 1998; 3 (3): 311–32.
21. Klein N, Soules M. endocrine changes of the perimenopause. Clin Obstet Gynecol 1998; 41 (4): 912–20.
22. Kubba A. Contraception: a review. IJCP 1998; 52 (2): 102–5.
23. Lahteenmaki P. Health benefits of a levonorgestrel-releasint IUD (abstract). 7th European congress of Gynaecology and Obstetric, 1992; 28 June – 1 July, Helsinki, Finland.
24. Lahteenmaki P, Bardin C, eloma K et al. Selection and performance of the levonorgestrel-releasing intrauterine system. Obstet Gynaecol Scand 1997; 164: 69–74.
25. Mandelin E, Koistinen H, Koistinen R et al. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin-A in endometrium during midcycle: another contraceptive mechanism. Hum Reprod 1997; 12 (12): 2671–5.
26. Nilsson CS, Lahteenmaki PLA, Luukkainen T. Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device. Fert Steril 1984; 41 (1): 52–55.
27. Ortiz ME, Croxatto H. Mode of action of IUDs//intrauterine Pakarinen P, Lahteenmaki P, Rutanen e. The effect of intrauterine and oral levonorgestrel administration on serum contracentrations of sex hormone – binding globulin, insulin and insulin-like growth factor binding protein-1. Acta Obstet Gynaecol 1999; 78 (5): 423–8.
28. Pakarinen P, Toivonen J, Luukkainen T. Randomized comprasion of a levonorgestrel- and copper-releasing system immediately after abortion, with 5 years folow up. contraception 2003; 68: 31–4.
29. Pekonen F, Nyman R, Lahteenmaki P et al. Intrauterine progestin induces continuous insulin growth factor-binding protein-1 production on the human endometrium. J Clin rndocrinol Metab 1992; 75: 660–4.
30. Rutanen E. Endometrial response to intrauterine release of levonorgestrel. Gynaecology Forum 1998; 3 (3): 11–3.
31. Rybo G. Tretment of menorrhagia using intrauterine administration of levonorgestrel. Gynecology Forum 1998; 3 (3): 20–2.
32. Sivin I, Health during prolonged use of levonorgestrel 20 micrograms/d and the Copper TCu 380 Ag intrauterine contraceptive devices: a multicenter study. International committe for contraception research (ICCR). Fertil Steril 1994; 61: 70–7.
33. Stewart A et al. The effectiveness of the levoneorgestrel-releasing intrauterine system in menorrhagia: a systematic review. BJOG: an International Journal of Obstetrics & Gynecology 2001; 108: 74–86.
34. Sturridge F, Guillebaund J. Gynaecological aspects of the levoneorgestrel-releasing intrauterine system. Brit J Obstet Gynaecol 1997; 104 (3): 285–9.
35. Suhonen S, Alonen H, Lahteenmaki P. Sustained-release estradiol implants and levonorgestrel-releasing intrauterine device in hormone replacement therepy. Am J Obstet Gynaecol 1995; 172: 562–7.
36. Suhonen S, Holmstrom T, allonen H et al. Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy. Fertil Steril 1995; 63: 336–42.
37. Suvisaari I, Lahteenmaki P. Detailed analysis of menstrial bleeding patterns after postmenstrial and postbortal insertion of cooper IUD or a levonorgestrel-releasing intrauterine system. Contraception 1996; 54: 4.
38. Toivonen J, Luukkainen T et al. Postabortal insertion of a levonorgestrel releasing IUD (Abstract). Gynecol Endocrinol 1995; FC 23.
39. Toivonen J, Luukkainen T, Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol 1991; 77 (2): 261–4.

А.В.Тагиева, П.Р.Абакарова

ГУ Научный центр акушерства, гинекологии и перинатологии РАМН (дир. – акад. РАМН В.И.Кулаков), Москва